FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
London Biotechnology Show 2026
London Biotechnology Show 2026 will unite global biotech leaders, pharmaceutical companies, investors,…
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory to Expand BCG Supply in the United States
ImmunityBio has signed an exclusive U.S. development and supply agreement with Japan…
FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B
The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis…
Takeda appoints Hernán Porcile as Head of the EAMEA region
Takeda has appointed Hernán Porcile as the new Area Head for its…
The 93rd API China
Gathering 60,000+ pharma professionals from 5000+ API,Chemical drugs, BioPharma and formulated TCM…
Sanofi Expands Immunology Footprint with $9.1 Billion Blueprint Medicines Acquisition
Sanofi has announced an agreement to acquire Blueprint Medicines Corporation, a US-based…
GSK to Advance Innovative Liver Disease Treatment with Acquisition of Efimosfermin
GSK has announced its acquisition of efimosfermin alfa, a promising new medicine…
